Cyberonics To Present At The Barclays Global Healthcare Conference

HOUSTON, March 3, 2015 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the Barclays Global Healthcare Conference on Wednesday, March 11, 2015, in Miami.

Dan Moore, Cyberonics' President and Chief Executive Officer, will speak at 1:05 PM Eastern Time.  The session will be conducted in a fireside chat format, and no formal materials will be presented.  A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at www.cyberonics.com on March 11, 2015.      

About Cyberonics, Inc. and the VNS Therapy^® System

Cyberonics, Inc. is a medical device company with core expertise in neuromodulation.  The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com.

Contact Information

Greg Browne, CFO
Cyberonics, Inc.
100 Cyberonics Blvd.
Houston, TX 77058
Main:  (281) 228-7262
Fax:  (281) 218-9332
ir@cyberonics.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cyberonics-to-present-at-the-barclays-global-healthcare-conference-300044019.html

SOURCE Cyberonics, Inc.